American Cancer Society INC
EIN 131788491 · GA · 501(c)03
The organisation
- 270 PEACHTREE ST NW STE 1300, ATLANTA, GA, 30303-1246, GA 30303-1246
- Classified purpose: Voluntary Health Associations & Medical Disciplines
- Size band: 9
Source: IRS Tax-Exempt Organization filings and the Exempt Organization Business Master File. US Federal Government public domain. Board history observed across annual filings.
Board at a glance
Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 19 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.
Renewal outlook
Medium-priority approach observed from annual filings
- Large organisation (revenue $724m) - the scale that runs a formal, external board search.
- The board chair has served at least 7 years (observed across filings) - a chair transition may be approaching.
A computed likelihood from the observed filing history and filed revenue. It is not a confirmed vacancy, and this edition never states that a nonprofit is recruiting. "Departures" mean a board member was on the previous filing but not the latest one, which usually means a seat opened but can also mean they were simply not listed that year.
Filed finances
| Tax year | Total revenue | Total expenses |
|---|---|---|
| 2024 | $724.2m | $791.9m |
As filed on the IRS Form 990.
The board (directors and trustees)
| Name | Title as filed | On the filings |
|---|---|---|
| Brian A Marlow CFA Chair | BOARD CHAIR | on filings since 2018 (at least 7y) |
| Michael T Marquardt Chair | BOARD IMMEDIATE PAST CHAIR | on filings since 2018 (at least 7y) |
| Asif Dhar MD MBA | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Connie Lindsey | BOARD SECRETARY | on filings since 2023 (at least 2y) |
| Desiree G Rogers | BOARD DIRECTOR | on filings since 2024 (at least 1y) |
| Edison T LIU MD (also filed as Edison T Liu MD) | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Jaime Wesolowski | BOARD DIRECTOR | on filings since 2024 (at least 1y) |
| Jose C Buenaga MBA | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Karen Etzkorn | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Kathleen Gallagher MSN | BOARD TREASURER | on filings since 2023 (at least 2y) |
| Katie A Eccles ESQ (also filed as Katie A Eccles, Katie A Eccles Esq) | BOARD DIRECTOR | on filings since 2020 (at least 5y) |
| Kenneth R Stoll | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Mark A Goldberg MD | BOARD SCIENTIFIC OFFICER | on filings since 2019 (at least 6y) |
| Michael Pellini MD | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Michelle M LE Beau PHD (also filed as Michelle M Le Beau PhD) | BOARD DIRECTOR | on filings since 2019 (at least 6y) |
| Norman E Sharpless MD | BOARD DIRECTOR | on filings since 2024 (at least 1y) |
| Robert Winn MD | BOARD DIRECTOR | on filings since 2023 (at least 2y) |
| Sean T Farnham | BOARD DIRECTOR | on filings since 2024 (at least 1y) |
| Terri Mcclements | BOARD VICE CHAIR | on filings since 2019 (at least 6y) |
The board is the directors and trustees named in Part VII of the organisation's annual IRS Form 990; officers and senior staff are listed separately below, not counted as board. The IRS files no appointment date, so tenure here is observed from how many years a person appears on the filings - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations.
Source: IRS Tax-Exempt Organization filings and the Exempt Organization Business Master File. US Federal Government public domain. Board history observed across annual filings.
Officers and senior leadership
Named in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.
| Name | Title as filed | On the filings |
|---|---|---|
| Andre C Bokhoor | Chief People Officer | since 2023 |
| Arif Kamal | Chief Patient Officer | since 2023 |
| Catherine E Mickle | CHIEF ADMINISTRATIVE OFFICER | since 2018 |
| David J Benson | EVP, NORTH REGION | 2018 |
| Emily Sandman | Senior Vice President, People | since 2023 |
| Gary M Reedy | CHIEF EXECUTIVE OFFICER | since 2018 |
| Irma Shrivastava | SVP, STRATEGIC MKTG ALLIANCES | 2018 |
| Jeff D Klaas | EVP, WEST REGION | since 2019 |
| Jeffrey D Fehlis | EXECUTIVE VICE PRESIDENT | 2020 |
| John B Woodward | Senior EVP, Field Operations | since 2023 |
| Jung H KIM | EVP, NORTHEAST REGION | since 2018 |
| Kael Reicin | Chief Fin. & Strategy Officer | since 2020 |
| Karen E Knudsen PHD | Chief Executive Officer | since 2023 |
| Kimberly Martinez | Chief Marketing Officer | 2023 |
| Leonard Lichtenfeld | DEPUTY CHIEF MEDICAL OFFICER | since 2019 |
| Michael L Neal | SENIOR EVP, FIELD OPS | since 2018 |
| Otis W Brawley | CHIEF MED & SCI OFC, OUTGOING | 2018 |
| Richard C Wender | CHIEF CANCER CONTROL OFFICER | since 2018 |
| Robert L Crutchfield | MANAGING DIR., BRIGHTEDGE VENTURES | 2019 |
| Robert M King | CFO, OUTGOING | since 2018 |
| Sharon Byers | CHIEF DEVELOPMENT & MARKETING OFCR | since 2018 |
| Susan G Herrington | EVP, ENTERPRISE GOV. & CORP. SVCS | 2019 |
| Tawana Thomas-Johnson | SENIOR VICE PRESIDENT, CHIEF DIVERSITY OFFICER | 2024 |
| Timothy B Phillips | Chief Legal and Risk Officer | since 2018 |
| Wayne A I Frederick MD MBA Facs | INTERIM CEO | 2025 |
| William Cance | CHIEF MEDICAL & SCIENTIFIC OFCR | 2020 |
| William L Dahut | Chief Scientific Officer | since 2023 |
| Wilton W White | EXECUTIVE VICE PRESIDENT | since 2018 |